ペプチドリームの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/09/06 | 1,552 | 1,616 | 1,552 | 1,614 | +62 | +4% | 610,500 |
| 2022/09/05 | 1,546 | 1,567 | 1,523 | 1,552 | -11 | -0.7% | 722,100 |
| 2022/09/02 | 1,623 | 1,633 | 1,558 | 1,563 | -49 | -3% | 1,124,600 |
| 2022/09/01 | 1,637 | 1,640 | 1,612 | 1,612 | -69 | -4.1% | 806,800 |
| 2022/08/31 | 1,645 | 1,687 | 1,627 | 1,681 | +28 | +1.7% | 654,500 |
| 2022/08/30 | 1,625 | 1,659 | 1,618 | 1,653 | +16 | +1% | 695,300 |
| 2022/08/29 | 1,670 | 1,702 | 1,636 | 1,637 | -109 | -6.2% | 1,068,800 |
| 2022/08/26 | 1,749 | 1,797 | 1,737 | 1,746 | +12 | +0.7% | 1,391,400 |
| 2022/08/25 | 1,621 | 1,735 | 1,618 | 1,734 | +147 | +9.3% | 1,430,700 |
| 2022/08/24 | 1,596 | 1,611 | 1,577 | 1,587 | -34 | -2.1% | 616,700 |
| 2022/08/23 | 1,646 | 1,649 | 1,621 | 1,621 | -60 | -3.6% | 605,700 |
| 2022/08/22 | 1,678 | 1,690 | 1,669 | 1,681 | -37 | -2.2% | 556,600 |
| 2022/08/19 | 1,719 | 1,738 | 1,706 | 1,718 | -21 | -1.2% | 610,000 |
| 2022/08/18 | 1,701 | 1,740 | 1,683 | 1,739 | -6 | -0.3% | 636,700 |
| 2022/08/17 | 1,715 | 1,754 | 1,673 | 1,745 | +35 | +2% | 1,018,700 |
| 2022/08/16 | 1,656 | 1,720 | 1,649 | 1,710 | +80 | +4.9% | 1,255,600 |
| 2022/08/15 | 1,651 | 1,663 | 1,620 | 1,630 | +16 | +1% | 752,500 |
| 2022/08/12 | 1,520 | 1,619 | 1,503 | 1,614 | +126 | +8.5% | 1,493,800 |
| 2022/08/10 | 1,601 | 1,602 | 1,476 | 1,488 | -181 | -10.8% | 1,803,700 |
| 2022/08/09 | 1,680 | 1,709 | 1,655 | 1,669 | +10 | +0.6% | 827,900 |
| 2022/08/08 | 1,664 | 1,693 | 1,654 | 1,659 | -18 | -1.1% | 573,300 |
| 2022/08/05 | 1,666 | 1,712 | 1,650 | 1,677 | +51 | +3.1% | 973,600 |
| 2022/08/04 | 1,612 | 1,633 | 1,597 | 1,626 | +44 | +2.8% | 777,800 |
| 2022/08/03 | 1,598 | 1,609 | 1,561 | 1,582 | -1 | -0.1% | 816,700 |
| 2022/08/02 | 1,625 | 1,639 | 1,578 | 1,583 | -45 | -2.8% | 640,900 |
| 2022/08/01 | 1,654 | 1,656 | 1,624 | 1,628 | -27 | -1.6% | 891,700 |
| 2022/07/29 | 1,603 | 1,664 | 1,588 | 1,655 | +86 | +5.5% | 1,434,700 |
| 2022/07/28 | 1,588 | 1,588 | 1,528 | 1,569 | -5 | -0.3% | 3,791,800 |
| 2022/07/27 | 1,566 | 1,595 | 1,558 | 1,574 | +8 | +0.5% | 782,000 |
| 2022/07/26 | 1,556 | 1,574 | 1,546 | 1,566 | -11 | -0.7% | 604,500 |
| 2022/07/25 | 1,542 | 1,584 | 1,535 | 1,577 | -5 | -0.3% | 810,400 |
| 2022/07/22 | 1,623 | 1,623 | 1,568 | 1,582 | -20 | -1.2% | 838,100 |
| 2022/07/21 | 1,596 | 1,624 | 1,586 | 1,602 | +8 | +0.5% | 726,500 |
| 2022/07/20 | 1,563 | 1,599 | 1,549 | 1,594 | +68 | +4.5% | 846,300 |
| 2022/07/19 | 1,547 | 1,549 | 1,474 | 1,526 | -3 | -0.2% | 862,600 |
| 2022/07/15 | 1,581 | 1,592 | 1,529 | 1,529 | -51 | -3.2% | 1,234,300 |
| 2022/07/14 | 1,515 | 1,591 | 1,510 | 1,580 | +50 | +3.3% | 835,900 |
| 2022/07/13 | 1,545 | 1,549 | 1,493 | 1,530 | -20 | -1.3% | 852,900 |
| 2022/07/12 | 1,540 | 1,568 | 1,507 | 1,550 | -6 | -0.4% | 1,112,600 |
| 2022/07/11 | 1,592 | 1,594 | 1,540 | 1,556 | -6 | -0.4% | 1,102,500 |
| 2022/07/08 | 1,519 | 1,570 | 1,499 | 1,562 | +41 | +2.7% | 1,564,000 |
| 2022/07/07 | 1,519 | 1,534 | 1,480 | 1,521 | +31 | +2.1% | 1,212,000 |
| 2022/07/06 | 1,409 | 1,514 | 1,408 | 1,490 | +106 | +7.7% | 1,659,900 |
| 2022/07/05 | 1,396 | 1,416 | 1,376 | 1,384 | -11 | -0.8% | 502,700 |
| 2022/07/04 | 1,407 | 1,434 | 1,384 | 1,395 | +24 | +1.8% | 655,200 |
| 2022/07/01 | 1,400 | 1,442 | 1,359 | 1,371 | -51 | -3.6% | 1,108,700 |
| 2022/06/30 | 1,456 | 1,470 | 1,414 | 1,422 | -11 | -0.8% | 841,900 |
| 2022/06/29 | 1,406 | 1,437 | 1,399 | 1,433 | -21 | -1.4% | 1,066,200 |
| 2022/06/28 | 1,389 | 1,454 | 1,384 | 1,454 | +43 | +3% | 1,038,000 |
| 2022/06/27 | 1,373 | 1,419 | 1,372 | 1,411 | +74 | +5.5% | 1,257,000 |
651～
700
件表示中 / 2908件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ペプチド | 190,600円 | +5.0% | +1.5% | 0.00% | 16.36倍 | 4.35倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 住友ファーマ | 89,900円 | +26.8% | - | 0.00% | 15.13倍 | 3.13倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 432,700円 | +20.9% | +87.3% | 3.14% | 9.66倍 | 1.11倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 348,400円 | +7.9% | +8.9% | 3.56% | 7.45倍 | 1.00倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| サワイＧＨＤ | 201,600円 | +4.0% | +25.4% | 2.63% | 8.82倍 | 1.16倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
市場注目の銘柄
チャート関連のコラム
